Soluble ST2 Testing: A Promising Biomarker in the Management of Heart Failure - Wikidata - wikimedia - TriplyDB

Soluble ST2 Testing: A Promising Biomarker in the Management of Heart Failure

Soluble ST2 Testing: A Promising Biomarker in the Management of Heart Failure

http://www.wikidata.org/entity/Q28066438

about

Soluble suppression of tumorigenicity-2 for risk stratification in outpatients with heart failure.A meta-analysis of soluble suppression of tumorigenicity 2 (sST2) and clinical outcomes in pulmonary hypertension.

P2860

Q55134579-95764E66-1878-4949-940B-01746B04FE4D Q55295899-C743377D-BD49-4207-A5EE-520CB4FFA051

P2860

Soluble ST2 Testing: A Promising Biomarker in the Management of Heart Failure

http://www.wikidata.org/entity/Q28066438

description

2016 nî lūn-bûn

@nan

2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Soluble ST2 Testing: A Promising Biomarker in the Management of Heart Failure

@ast

Soluble ST2 Testing: A Promising Biomarker in the Management of Heart Failure

@en

Soluble ST2 Testing: A Promising Biomarker in the Management of Heart Failure

@nl

type

label

Soluble ST2 Testing: A Promising Biomarker in the Management of Heart Failure

@ast

Soluble ST2 Testing: A Promising Biomarker in the Management of Heart Failure

@en

Soluble ST2 Testing: A Promising Biomarker in the Management of Heart Failure

@nl

prefLabel

Soluble ST2 Testing: A Promising Biomarker in the Management of Heart Failure

@ast

Soluble ST2 Testing: A Promising Biomarker in the Management of Heart Failure

@en

Soluble ST2 Testing: A Promising Biomarker in the Management of Heart Failure

@nl

P1433

Q28066438-EA7E79BD-D235-4914-958E-F32DED1D6EFD

P1476

Q28066438-EEDCE341-B407-47BF-9455-E9A84862FC2A

P2093

Q28066438-E84ACC0D-B8AF-4F45-ADB4-3BA2624CD1D5

Q28066438-F17634B3-726B-48BE-970F-15B56FE7203C

P275

Q28066438-E14E3C05-E898-4F01-A8FB-9D0494647DB4

P2860

Q28066438-0E08E4A2-0B83-4661-B6EB-84B0D10D8D7F

Q28066438-13A61186-B078-45E9-8863-958DAE7FF92B

Q28066438-1B8DE7A7-4D62-4054-AEE7-85D7A4B343FB

Q28066438-221E4E79-3461-4C38-B714-904F154C0222

Q28066438-22A5FFAD-01FE-4D62-AADE-028137945C9A

Q28066438-2D73EF83-11BF-4E51-BD6F-C2BA9E6580DC

Q28066438-30CE34E1-4BAD-4070-972E-D52425072E8D

Q28066438-39C856D8-422B-4E18-B024-2D19D474A7E7

Q28066438-3C68B9AD-48F4-4A03-9D70-D464601CA8BF

Q28066438-3EB3AD55-69D6-48A3-BDFD-5E79AEFA659D

P304

Q28066438-3C3E1B10-CA76-4BEA-8ECF-FC65CD9C4481

P31

Q28066438-23AD1CBA-8D6E-4E76-BAC3-1D83D3D91B47

Q28066438-DFCC8A82-4291-481B-B824-E2D6E1E7C9E4

P356

Q28066438-E82FCA3F-0541-47F2-9033-BA72BEF2ED75

P407

Q28066438-5C3489B2-76B7-4D44-B70A-B122D1BFCF0C

P433

Q28066438-3A16EDBD-B0DF-41FC-B2D2-83A68EDDDC1D

P478

Q28066438-1819761F-0B81-4DFA-8F59-90F3CF8A9E00

P5008

Q28066438-17947744-D811-4036-AACF-4F7FD61BCB44

P577

Q28066438-51CD4A2C-2D87-4C0A-8968-6C84894BE3CC

Q28066438-9B956AAC-195B-42D0-9630-4E4F02C5B8E3

P698

Q28066438-BCC68CEE-0549-4CD1-A446-F89977CE5E6A

P921

Q28066438-171E6E00-0340-4F2D-934E-2554D6F4B6DD

Q28066438-47C31DD8-8742-4914-81E0-59A8A229995B

Q28066438-587C0526-2DD1-436B-A73B-A51BD7643996

Q28066438-C954613B-9EA5-4624-9972-CEA9B2F63690

P932

Q28066438-48524EDA-39EA-450A-B566-08F3127B3A2B

P356

P1433

Arquivos Brasileiros De Cardiologia

P1476

Soluble ST2 Testing: A Promising Biomarker in the Management of Heart Failure

@en

P2093

Alan S. Maisel

http://www.w3.org/2001/XMLSchema#string

Humberto Villacorta

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure

Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction

Serial sampling of ST2 predicts 90-day mortality following destabilized heart failure

Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

ST2 and patient prognosis in chronic heart failure.

Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction.

The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis.

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.

P304

145-52

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5935/ABC.20150151

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2016-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26761075

http://www.w3.org/2001/XMLSchema#string

P921

cell surface receptor

membrane proteins

P932

4765013

http://www.w3.org/2001/XMLSchema#string